CLINICAL_TRIALS
research
· 2010-03-19
Clinical Trial Update: Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir [Phase 3]
Summary
This is a Phase 3 open and comparative trial evaluating tolerability and efficacy of Taro Elixir for acne vulgaris and furuncles, sponsored by Laboratorios Goul…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Laboratorios Goulart S.A. | Conditions: Acne Vulgaris II or III Degree, Boils | Phase 3 | Status: UNKNOWN